Article
Control of the innate immune response by the mevalonate pathway.
Nature immunology - 1 Aug 2016
Akula Murali K, Shi Man, Jiang Zhaozhao, Foster Celia E, Miao David, Li Annie S, Zhang Xiaoman, Gavin Ruth M, Forde Sorcha D, Germain Gail, Carpenter Susan, Rosadini Charles V, Gritsman Kira, Chae Jae Jin, Hampton Randolph, Silverman Neal, Gravallese Ellen M, Kagan Jonathan C, Fitzgerald Katherine A, Kastner Daniel L, Golenbock Douglas T, Bergo Martin O, Wang Donghai
Abstract excerpt
Deficiency in mevalonate kinase (MVK) causes systemic inflammation. However, the molecular mechanisms linking the mevalonate pathway to inflammation remain obscure. Geranylgeranyl pyrophosphate, a non-sterol intermediate of the mevalonate pathway, is the substrate for protein geranylgeranylation, a protein post-translational modification that is catalyzed by protein geranylgeranyl transferase I (GGTase I). Pyrin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.